Saint John Regional Hospital Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2012
NCT01577524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Atlantic Health Sciences Corp - Saint John Regional Hospital, Saint John NB Canada | Neurosurgery Department, Saint John Regional Hospital

Active Ingredients

Drugs in Phase 2 Trials (2)

povidone-iodine (betadine) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (4)

cisplatin (platinol) (1 trial)

gemcitabine (gemzar) (1 trial)

romidepsin (istodax) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 1)

Lymphoma, B-Cell (Phase 1)

Lymphoma, Large B-Cell, Diffuse (Phase 1)

Lymphoma, T-Cell, Peripheral (Phase 1)

Surgical Wound Infection (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 6